In May 2012, the U.S. Preventive Services Task Force recommended against routine PSA screening (Prostate-Specific Antigen test to screen Prostate cancer) before being diagnosed as it did not benefit patients.

FORBES: Intuitive Surgical Earnings Preview: What We Are Watching

Last month the task force advised against routine prostate-specific antigen (PSA) tests to screen for prostate cancer.

ECONOMIST: The philosophical error that plagues American health care

Fortunately, earlier diagnosis of prostate cancer, thanks to prostate-specific antigen (PSA) testing, may have slowed and even reversed these trends, according to the study, which was published in the Journal of the National Cancer Institute.

CNN: STORY HIGHLIGHTS